Safety-net providers once often overcharged for medications covered under the federal cost-saving program have a new resource to protect against it.
The Health Resources & Services Administration (HRSA) has launched a new secure website intended to serve as a tool through which safety-net healthcare providers participating in the 340B federal drug pricing program can determine the maximum prices pharmaceutical companies can charge them for medications sold to them under the program, Administration officials announced this week.
In 2010, HRSA noted in a press release, Congress mandated that the government calculate and list such “ceiling prices” following reports by the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) that documented a pattern of overcharges. That legislation also created civil monetary penalties for drug manufacturers that “knowingly and intentionally” overcharge safety-net hospitals for 340B drugs.
The penalties took effect in January 2019.
“Today marks a positive milestone in the history of the 340B drug pricing program,” 340B Health President and CEO Maureen Testoni said in a statement. “Today’s launch of a secure website listing the maximum allowable prices for all 340B covered drugs brings a healthy dose of sunshine into a marketplace that has, for far too long, been a black box. Until today, hospitals, clinics, and health centers participating in 340B had no way to be sure they were paying the correct amount for the drugs they purchase.”
Testoni will be the featured guest on today’s edition of Monitor Mondays, the weekly healthcare news web broadcast produced by RACmonitor.
Annual spending in the 340B program has reportedly approached $20 billion during recent years, or approximately triple the rate of a decade ago. That sum represents a little more than 5 percent of all domestic drug sales.
In the past, Testoni noted, those payments undoubtedly amounted to considerably more than was allowable under the program.
“The Department of Health and Human Services (HHS) Office of Inspector General (OIG) has documented numerous instances of drug manufacturers overcharging safety-net providers for lifesaving medicines through 340B, undercutting resources designed to provide care to patients in need,” she said. “This overcharging led Congress to direct the Health Resources & Services Administration (HRSA) to create (this) secure website, where the agency can post the 340B ceiling price for every drug sold to those providers. It has taken nine years to see that law turned into action, but we are pleased to see it happen.”
“Starting today,” Testoni added, “authorized personnel working for 340B providers can check the HRSA website and ascertain whether they are being charged the correct amounts. With this new transparency comes a needed increase in accountability for drug manufacturers. When this information is combined with the civil monetary penalty authority that Congress granted HRSA, manufacturers that knowingly and intentionally charge safety-net providers too much will be subject to financial penalties.”
Testoni singled out HRSA’s Office of Pharmacy Affairs and its leader, Captain Krista Pedley, for making it all possible.
For more information about the 340B program, including access to periodic updates and a series of FAQs, go online to https://www.hrsa.gov/opa/index.html.
Programming Note:
Listen to Maureen Testoni report this story live during today’s Monitor Monday, 10-10:30 a.m. EST.
The federal government may have shut down, but there has been no pause for the 340B drug pricing program. The more than 1,600 safety-net hospitals
Following the U.S. Supreme Court’s unanimous 2022 decision striking down the Centers for Medicare & Medicaid Services’ (CMS’s) differential 340B payment rates, providers faced a
Please log in to your account to comment on this article.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Get clear, practical answers to Medicare’s most confusing regulations. Join Dr. Ronald Hirsch as he breaks down real-world compliance challenges and shares guidance your team can apply right away.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
